Carpal Tunnel Syndrome Tied to Increased Incidence of Heart Failure
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, July 14, 2023 -- Carpal tunnel syndrome (CTS) is associated with an increased incidence of new-onset heart failure, according to a research letter published online July 12 in JAMA Network Open.
Mark Luedde, M.D., from the University of Kiel in Germany, and colleagues conducted a retrospective cohort study involving adult patients from 1,284 general practices in Germany with an initial diagnosis of CTS to examine the association with heart failure. The cohort included 81,898 patients with CTS, who were propensity score-matched to 81,898 without CTS.
The researchers found that 10 years after the index date, 8.4 and 6.2 percent of patients with and those without CTS, respectively, received a diagnosis of heart failure (incidence, 8.7 versus 6.1 cases per 1,000 patient-years). In a regression analysis, a significant association was seen between CTS and subsequent heart failure diagnosis (hazard ratio, 1.39). The association was comparable for women and men (hazard ratios, 1.40 and 1.38, respectively). CTS was significantly associated with heart failure among patients aged 61 to 70 years and older than 70 years (hazard ratios, 1.48 and 1.48, respectively), but not among those aged 18 to 40, 41 to 50, or 51 to 60 years.
"Our study reveals an association between CTS and heart failure," the authors write. "Thus, we point to a new role for surgeons together with general practitioners in the early detection of important internal diseases, a chance for better treatment, and an improved prognosis of these diseases."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2023
Read this next
Semaglutide Reduces Need for Diuretics in Heart Failure
THURSDAY, May 16, 2024 -- Semaglutide reduces the need for loop diuretics and has positive effects on symptoms, physical limitations, and body weight in patients with heart...
Male, Female V1421 Carriers Face Similar Risk for Heart Failure Hospitalization
THURSDAY, May 16, 2024 -- Male and female V1421 carriers face a similar and substantial risk for heart failure hospitalization, according to a study published online May 12 in the...
Implantable Continuous Flow Device Feasible for Small Children With Severe Systolic Heart Failure
FRIDAY, May 10, 2024 -- The Jarvik 2015 left ventricular assist device (LVAD) seems promising as an implantable continuous flow device for small children with severe systolic...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.